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Objectives: Sarcopenia may negatively affect short-term outcomes after liver resection. The present
study aimed to explore whether total functional liver volume (TFLV) is related to sarcopenia in patients
undergoing partial liver resection.
Methods: Analysis of total liver volume and tumour volume and measurements of muscle surface were
performed in patients undergoing liver resection using OsiriX® and preoperative computed tomography.
The ratio of TFLV to bodyweight was calculated as: [TFLV (ml)/bodyweight (g)]*100%. The L3 muscle
index (cm2/m2) was then calculated by normalizing muscle areas (at the third lumbar vertebral level) for
height.
Results: Of 40 patients, 27 (67.5%) were classified as sarcopenic. There was a significant correlation
between the L3 skeletal muscle index and TFLV (r = 0.64, P < 0.001). Median TFLV was significantly lower
in the sarcopenia group than in the non-sarcopenia group [1396 ml (range: 1129–2625 ml) and 1840 ml
(range: 867–2404 ml), respectively; P < 0.05]. Median TFLV : bodyweight ratio was significantly lower in
the sarcopenia group than in the non-sarcopenia group [2.0% (range: 1.4–2.5%) and 2.3% (range:
1.5–2.5%), respectively; P < 0.05].
Conclusions: Sarcopenic patients had a disproportionally small preoperative TFLV compared with
non-sarcopenic patients undergoing liver resection. The preoperative hepatic physiologic reserve may
therefore be smaller in sarcopenic patients.
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Introduction
Over recent decades, liver resection has become increasingly safe
as a result of improvements in surgical techniques and periopera-
tive care. At present, mortality rates are reported to be well below
5%.1,2 However, postoperative liver failure remains the most
important cause of lethal outcome after liver surgery. Patients
with a small postoperative remnant liver volume (RLV) are at
higher risk for developing post-resection liver failure. The critical
minimum RLV has been estimated to be approximately 25% after
resection in normally functioning livers.3 It is still unclear why
some patients with smaller hepatic remnants do not develop liver
failure or postoperative complications, whereas some with greater
residual volumes do. In addition, postoperative morbidity
remains a concern in these patients. Therefore, it is of major
importance to preoperatively identify patients who are at
increased risk for postoperative liver failure and related morbidity.
Unfortunately, at present there is no adequate method for assess-
ing this risk in patients undergoing liver resection.
Information on body composition and the metabolic status of
patients undergoing liver resectionmay help to identify patients at
increased risk. Patients undergoing liver surgery often suffer from
weight loss or even cachexia as a result of malignancies or as a
consequence of chemotherapy toxicity. Central to the progress of
cancer-related weight loss is the development of sarcopenia. Sar-
copenia, defined as the depletion of musclemass, is proven to affect
short-term outcome negatively after liver resection4 and has also
been associated withmortality in patients with cirrhosis scheduled
for liver transplantation.5 A recent study by van Vledder et al.6
showed that sarcopenia was a strong indicator for a worse
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prognostic outcome in terms of both disease-free and overall sur-
vival after liver resection. It is currently unknownwhether sarcope-
nia is associated with a decrease in total hepatic functional mass.
The present study hypothesized that sarcopenic patients may have
impaired outcome after liver surgery because their preoperative
total functional liver volume (TFLV) is disproportionally small
compared with that in non-sarcopenic patients. The present study
was intended to explore whether TFLV is related to the level of
sarcopenia in patients undergoing partial liver resection.
Materials and methods
Ethics approval
The study was approved by the medical ethics committee of Maas-
tricht University Medical Centre and conducted according to the
revised version of the Declaration of Helsinki (October 2008,
Seoul). All patients had given written informed consent to the
inclusion of their data in a prior study. For the current purpose, no
new approval was needed as this prior consent covered the use of
these data in related studies conducted within 5 years.
Patients
Patients with primary or secondary liver tumours (mostly col-
orectal cancer liver metastases) in otherwise normal livers planned
for liver resection at Maastricht University Medical Centre
between January 2008 and June 2009 were eligible for inclusion in
this study. All patients underwent contrast-enhanced computed
tomography (CT) within routine preoperative assessment at
either the present hospital or at one of the surrounding university-
affiliated district general teaching hospitals. Patients were admit-
ted to the hospital 1 day preoperatively and were submitted to
routine blood tests.
Surgical procedure
Liver resection was performed as detailed elsewhere.7 In each
patient, laparotomy was performed by bilateral subcostal incision,
after which intraoperative ultrasound was used to assess the liver,
which was then mobilized appropriately prior to hepatic paren-
chymal transection.
Image muscle area analysis using OsiriX®
All patients underwent contrast-enhanced CT as part of routine
preoperative assessment. Image analysis was conducted using
four-phase CT scans provided on CD-ROM. The muscle and liver
areas were outlined using the open-source software OsiriX®
Version 3.3 (32-bit; http://www.osirix-viewer.com). A 2.8-GHz
Intel Core 2 Duo 24″ iMac (Apple, Inc., Cupertino, CA, USA) was
used. Muscle areas were measured on transverse slices of the CT
scans in a semi-automated fashion by two investigators (SAWGD
and TML). The ‘Grow Region (2D/3D Segmentation)’ tool in the
‘Region of Interest’ (RoI) dropdown menu enabled the automatic
outlining of skeletal muscles. This modality of OsiriX® is based on
differences in Hounsfield units (HU) among muscle, bony struc-
tures and body fat. The threshold range for muscle was set
between -30 HU and 110 HU. If necessary, the automatically gen-
erated outlines were hand-adjusted with the ‘Closed Polygon
Selection’ and ‘Repulsor’ tools to optimize the RoI (Fig. 1).
Volumetric liver analysis using OsiriX®
Volumetric analysis using OsiriX® was performed by two investi-
gators (SAWGD and TML). Details on how volumetry was per-
formed with OsiriX® have been described previously.8 The total
liver volume (TLV) and the tumour volume (TV) were manually
outlined on the preoperative CT scan. The TFLV was calculated
using the following formula: TLV - TV = TFLV.
Calculations
Data are expressed as median and range. Skeletal muscle content
was assessed by measuring the cross-sectional areas of the muscles
at the level of the lumbar 3 (L3) vertebral landmark. Measure-
ments were performed on the first image on which both vertebral
spinae were clearly visible and on the following image in the
cranial direction. Area measurements were obtained for the fol-
lowing muscles: psoas; paraspinal muscles; transversus abdomi-
nis; external and internal oblique abdominis, and rectus
abdominis. The mean of the skeletal muscle area was used for
calculation. The measured skeletal muscle areas were then nor-
malized for height as is conventional for other body composition
measures to derive the L3 skeletal muscle index (L3mi) expressed
in cm2/m2. The ratio of TFLV : bodyweight was calculated as:
[TFLV (ml)/bodyweight (g)]*100%.
Total body fat-free mass was estimated by the method proposed
by Prado et al.9 using the following formula: total body fat-free
Figure 1 Computed tomography image at the third lumbar vertebral
level. The following skeletal muscles are outlined in red: rectus
abdominis; oblique and lateral abdominal muscles; paraspinal
muscles, and psoas. This female sarcopenic patient had an L3
muscle index of 34.3 cm2/m2
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mass (kg) = 0·30*(skeletal muscle surface area at L3 in cm2) + 6.06.
Prado et al.9 constructed this formula with regression equations
relating muscle surface area in the lumbar region with total body
fat-free mass. Body surface area (BSA) was calculated using the
Mosteller formula: BSA (m2) = [(height, cm*weight, kg/3600)0.5].
Sarcopenia
The definition of sarcopenia was based on a method validated in
patients with cancer.9 In this method, cut-off values associated
with mortality are determined by optimal stratification. The L3mi
values associated with mortality determined in this way were
55.4 cm2/m2 for men and 38.9 cm2/m2 for women. Patients with
an L3mi lower than these values were considered sarcopenic.9
Statistics
Data are presented as median (range). Correlations were calcu-
lated using Pearson’s test. A P-value of <0.05 was considered
to indicate statistical significance. The resulting regression line
was described as a linear equation, and the correlation coefficient
(r) was calculated. The Mann–Whitney U-test was applied to
compare continuous data between groups. Statistical analysis was
performed using Prism 5.0 for Windows (GraphPad Software,
Inc., San Diego, CA, USA) and spss Version 18.0 (SPSS, Inc.,
Chicago, IL, USA).
Results
Patients
A total of 40 patients were evaluated in the present study. Their
median age was 62 years (range: 41–80 years) and median body
mass index (BMI) was 25.2 kg/m2. Thirty-seven patients under-
went liver resection because of colorectal liver metastases, two
patients because of hepatocellular carcinoma and one patient
because of a carcinoid metastasis. Patients were not infectious and
did not have liver dysfunction. The median L3mi was 49.5 cm2/m2
(range: 35.5–70.8 cm2/m2) in men and 38.4 cm2/m2 (range: 29.4–
61.0 cm2/m2) in women. Based on the predefined criteria, sarcope-
nia was identified in 27 patients (67.5%), including 17 of 24 (70.8
%) men and 10 of 16 (62.5%) women (Table 1).
Features associated with sarcopenia
Total liver volume, TFLV and fat-free body mass were signifi-
cantly lower in the sarcopenia group than in the non-sarcopenia
group (P < 0.05). The ratio of TFLV : bodyweight was also sig-
nificantly lower in the sarcopenia group than in the non-
sarcopenia group [2.0% (range: 1.4–2.5%) and 2.3% (range: 1.5–
2.5%), respectively; P < 0.05] (Fig. 2). Age, sex, weight and height
did not significantly differ between the sarcopenia and non-
sarcopenia groups. The association between sarcopenia and
BMI did not attain statistical significance (P = 0.06) (Table 2).
There was no significant correlation between age and L3mi
(r = 0.006, P = 0.97).
Relationship between body composition and TFLV
The average time required tomeasure the L3muscle areawas 4 min
per measurement per patient. There was a significant correlation
between skeletal L3mi and TFLV (r = 0.64, P < 0.001). There were
also significant correlations between TFLV and fat-free body mass
(r = 0.74, P < 0.001) and BSA (r = 0.78, P < 0.001) (Fig. 3a–c).
Table 1 Patient characteristics at the time of muscularity assess-
ment (n = 40 patients)
Variables Values
Age, years, median (range) 62 (41–80)
Sex, male, n (%) 24 (60.0)
Weight, kg, median (range) 76 (49–127)
Height, cm, median (range) 172 (155–195)
BMI, kg/m2, median (range) 25 (19.3–42.9)
Fat-free body mass, kg, median (range) 48 (31–66)
BSA, m2, median (range) 1.9 (1.47–2.46)
Preoperative laboratory tests, median (range)
Bilirubin, mmol/l (normal < 20) 11.8 (6.9–9.5)
ALT, U/l (normal < 50) 26 (7–67)
AST, U/l (normal < 38) 21 (7–52)
LDH, U/l (normal 120–250) 367 (263–595)
Ggt, U/l (normal < 55) 45 (13–258)
CRP (normal < 10) 3 (1–88)
Creatinine, mmol/l (normal 60–115) 87 (46–287)
Preoperative muscle status, cm2/m2,
median (range)
L3 muscle index in all patients 46.4 (29.4–70.8)
L3 muscle index in men 49.5 (35.5–70.8)
L3 muscle index in women 38.4 (29.4–61.0)
Sarcopenic patients, n (%) 27 (62.5)
BMI, body mass index; BSA, body surface area; ALT, alanine aminotrans-
ferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase;
Ggt, g-glutamyl transferase; CRP, C-reactive protein.
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Figure 2 The calculated total functional liver volume (TFLV) : body-
weight ratio. *P < 0.05
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Discussion
The aim of the present study was to investigate whether TFLV was
influenced by the presence or absence of sarcopenia in patients
undergoing liver surgery. There was a significant correlation
between the L3mi and preoperative TFLV. The relationship
between body composition and TFLV was confirmed by signifi-
cant correlations between preoperative TFLV and both fat-free
body mass and BSA. Sarcopenic patients had a significantly lower
preoperative TFLV compared with non-sarcopenic patients.
Because a relationship between bodyweight and TLV is known to
exist, the TFLV : bodyweight ratio was subsequently calculated.10
The TFLV : bodyweight ratio was significantly lower in the sar-
copenia group than in the non-sarcopenia group, providing evi-
dence that liver weight is reduced to a disproportionally greater
extent in sarcopenic patients.
The data from the present study provide novel background
information that may help to explain the results reported by Peng
et al.4 and van Vledder et al.6 Both of these studies showed that
sarcopenia has a negative impact on postoperative outcome after
liver resection. However, the reason why outcomes are worse in
sarcopenic patients compared with non-sarcopenic patients
remains unclear. One explanation may be that the metabolic
physiologic reserve in sarcopenic patients is decreased. The rev-
elation by CT volumetric analysis of the liver in the present study
that preoperative TFLV is smaller in sarcopenic patients than in
non-sarcopenic patients supports this hypothesis. It may very well
be that patients with sarcopenia have worse outcomes after liver
surgery because their preoperative TFLV/hepatocyte mass is dis-
proportionally small compared with that in non-sarcopenic
patients. These findings underline the importance of assessing for
sarcopenia in addition to liver volumetry in patients scheduled for
liver resection.
It has been suggested that in healthy individuals the level of
sarcopenia is related to age.11 This was not found to be true in the
patients enrolled in the present study because there was no sig-
nificant difference in age between groups. There was also no sig-
nificant correlation between age and L3 muscle mass index. This
provides circumstantial evidence that the L3 muscle mass index
reflects the extent of sarcopenia in patients with liver tumours and
is not determined by age per se. Further, there was no significant
correlation between TV and level of sarcopenia.
The percentage future RLV is usually expressed as the ratio of
RLV : TLV (RLV/TLV*100%). The critical minimum RLV has
been estimated to be approximately 25% after resection.3,12–14
Truant et al.10 showed that the ratio of RLV to bodyweight
(RLV : BW) was more specific than RLV alone in predicting post-
operative course after extended hepatectomy. These authors
showed that a cut-off RLV : BW value of 0.5% can be used as a
critical point associated with postoperative outcome.10 As the L3
muscle mass index is probably a more robust indicator of physi-
ologic reserves and cachexia than bodyweight, perhaps an
RLV : L3mi ratio would be even more accurate in predicting
outcome after hepatectomy.
The extent of muscle wastage in sarcopenia is often underesti-
mated in cancer patients because a substantial proportion of
patients with sarcopenia have a BMI within the normal range and
some sarcopenic patients are even overweight.9 For instance, in the
present study none of the sarcopenic patients were underweight
(BMI < 18.5 kg/m2) and one sarcopenic patient was overweight.
Sarcopenic obese patients will probably be evenmore vulnerable in
major surgery because they are subject to the health risks of both
obesity and depleted lean bodymass.9 The L3muscle mass index is
a valuable tool for diagnosing frailty in patients with a normal or
high BMI.Assessingmusclemass preoperatively in patients under-
going liver surgery, in order to estimate physiologic metabolic
reserve,may soon become evenmore important as there are simul-
taneous incremental increases in the incidences of obesity and
primary and secondary liver tumours in the Western world.
In conclusion, sarcopenic patients had a disproportionally
small preoperative TFLV compared with non-sarcopenic patients
undergoing liver resection. The preoperative hepatic physiologic
reserve may therefore be disproportionally low in sarcopenic
patients compared with non-sarcopenic patients. The L3 muscle
Table 2 Features associated with sarcopenia in 40 patients
Variables No sarcopenia (n = 13) Sarcopenia (n = 27) P-value
Age, years, median (range) 60 (43–80) 64 (41–79) 0.735
Sex, male, n (%) 7 17 0.733
Weight, kg, median (range) 85 (49–127) 74 (54–106) 0.363
Height, m, median (range) 1.7 (1.6–1.9) 1.7 (1.6–2.0) 0.108
Body mass index, kg/m2, median (range) 29 (20–43) 25 (19–31) 0.06
Fat-free body mass, kg, median (range) 57 (36–67) 48 (31–60) <0.05
Body surface area, m2, median (range) 2.0 (1.5–2.5) 1.9 (1.5–2.3) 0.709
L3 muscle index, cm2/m2, median (range) 59 (40–71) 42 (29–53) <0.005
Total liver volume, ml, median (range) 1841 (919–2417) 1402 (1138–2630) <0.05
Tumour volume, ml, median (range) 13 (0–112) 8 (1–37) <0.05
Total functional liver volume, ml, median (range) 1840 (867–2404) 1396 (1129–2625) <0.05
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mass index is easily obtainable and may represent
a valuable additional tool for preoperative risk assessment in
patients undergoing partial liver resection.
Conflicts of interest
None declared.
References
1. Asiyanbola B, Chang D, Gleisner AL, Nathan H, Choti MA, Schulick RD
et al. (2008) Operative mortality after hepatic resection: are literature-
based rates broadly applicable? J Gastrointest Surg 12:842–851.
2. de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD et al.
(2009) Rates and patterns of recurrence following curative intent surgery
for colorectal liver metastasis: an international multi-institutional analysis
of 1669 patients. Ann Surg 250:440–448.
3. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ. (2005)
The value of residual liver volume as a predictor of hepatic dysfunction
and infection after major liver resection. Gut 54:289–296.
4. Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, Ng Y et al.
(2011) Sarcopenia negatively impacts short-term outcomes in patients
undergoing hepatic resection for colorectal liver metastasis. HPB 13:439–
446.
5. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE,
Bain VG et al. (2011) Muscle wasting is associated with mortality in
patients with cirrhosis. Clin Gastroenterol Hepatol 10:166–173.
6. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, IJzermans JN.
(2011) Body composition and outcome in patients undergoing resection
of colorectal liver metastases. Br J Surg 99:550–557.
7. Dejong CH, Garden OJ. (2003) Neoplasms of the liver. In: Majid AA,
Kingsnorth A, eds. Advanced Surgical Practice. London: Greenwich
Medical Media, pp. 146–156.
8. van der Vorst JR, van Dam RM, van Stiphout RS, van den Broek MA,
Hollander IH, Kessels AG et al. (2010) Virtual liver resection and volumet-
ric analysis of the future liver remnant using open source image process-
ing software. World J Surg 34:2426–2433.
9. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L
et al. (2008) Prevalence and clinical implications of sarcopenic obesity in
patients with solid tumours of the respiratory and gastrointestinal tracts:
a population-based study. Lancet Oncol 9:629–635.
10. Truant S, Oberlin O, Sergent G, Lebuffe G, Gambiez L, Ernst O et al.
(2007) Remnant liver volume to body weight ratio > or = 0.5%: a new
cut-off to estimate postoperative risks after extended resection in non-
cirrhotic liver. J Am Coll Surg 204:22–33.
11. Roubenoff R. (2003) Sarcopenia: effects on body composition and func-
tion. J Gerontol A Biol Sci Med Sci 58:1012–1017.
12. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S et al.
(2002) Improvement in perioperative outcome after hepatic resection:
analysis of 1803 consecutive cases over the past decade. Ann Surg
236:397–406; discussion 406–407.
13. Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz
LH et al. (2003) Volumetric analysis predicts hepatic dysfunction in
patients undergoing major liver resection. J Gastrointest Surg 7:325–330.
14. Ferrero A, Vigano L, Polastri R, Muratore A, Eminefendic H, Regge D et al.
(2007) Postoperative liver dysfunction and future remnant liver: where is
the limit? Results of a prospective study. World J Surg 31:1643–1651.
0 20 40 60 80
0
1000
2000
3000
L3 skeletal muscle index, cm2/m2
T
F
L
V
, m
l
0 20 40 60 80
0
1000
2000
3000
(a)
(b)
(c)
Fat-free body mass, kg
T
F
L
V
, m
l
1.0 1.5 2.0 2.5 3.0
0
1000
2000
3000
Body surface area, m2
T
F
L
V
, m
l
Figure 3 Correlations between total functional liver volume (TFLV) in
40 patients and (a) L3 muscle index (r = 0.64, P < 0.0001), (b) fat-free
body mass (r = 0.74, P < 0.0001), and (c) body surface area (r = 0.78,
P < 0.0001)
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